PeptideStack
5.2kquestions
20kanswers
220users

Does a phase-change pack hold a semaglutide shipment for twenty-eight days in transit?

Asked 4 Nov 2025Modified 9 months agoViewed 11k times
25

What I am working with: semaglutide · twenty-eight days.

Please show the division. I want to check my own against yours.

I would like the general form as well as the specific number, so I can apply it again.

Where is my error, and what is the correct working?

cold-chain
cold-chain

Keeping material within a temperature window from manufacture to use: phase-change packs versus dry ice, thermal mass, transit-lane temperature…

578 questionsinternational-shipping
international-shipping

Cross-border movement of research material: transit lanes and their thermal profiles, tracked versus untracked, declaration accuracy, and what…

471 questionsstorage
storage

Storage conditions and their evidence base: minus twenty degrees for powder, refrigerated for solution, protection from light, and what the…

701 questionssemaglutide
semaglutide

A GLP-1 receptor agonist with a fatty-acid-acylated backbone and a roughly one-week half-life, marketed for type 2 diabetes and for weight…

470 questions
shareeditfollowflag
BA
askedben_akintola10k164 Nov 2025
2Same question here after a warm delivery, so I am following this. – Dr_Idris_Coulibaly 7 months ago
Worth saying whether the vial has been opened, because that starts a different clock. – Dr_Ilse_Vandenberg 5 months ago
add a comment

No answers yet

This question has not been answered. It has been viewed 11k times, which suggests the question is of interest and the answer is not obvious. If you can answer it with a source or a worked calculation, it will be read. See how to ask and answer.
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.